Raj Chakraborty: Bispecific T-Cell Engagers for Multiple Myeloma

By Raj Chakraborty, MD - Last Updated: November 14, 2022

Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, speaks about bispecific T-cell engagers (BiTEs) for multiple myeloma, and considerations for selecting between BiTEs and CAR T-cell therapy in the clinic.

Advertisement

Post Tags:MM
Advertisement
Advertisement
Advertisement
Editorial Board